1759133731 this is an ai generated image used only for representative purpose.jpg

IPO boom in India: Nearly Rs 1.7 lakh crore raised in 2025; more companies to enter stock market

India’s initial public offering (IPO) market has made a remarkable comeback over the past year, raising nearly double the funds of the previous year even as broader stock markets struggled.Between October 2024 and September 2025, 86 IPOs brought in Rs 1,70,897 crore, compared with Rs 90,436 crore that 88 IPOs raised in the same period…

Read More
1759070504 unnamed file.jpg

Valuation watch: Top-10 most valued firms’ market cap drops by Rs 2.99 lakh crore; TCS emerges as the biggest hit on H1-B visa fees hike

The combined market valuation of India’s top-10 most valued companies shrank by Rs 2,99,661.36 crore last week, mirroring a bearish trend in equities, with IT bellwether Tata Consultancy Services (TCS) bearing the brunt.The BSE benchmark tanked 2,199.77 points or 2.66 per cent during the week, as investor sentiment was rattled by a series of domestic…

Read More
1759063224 unnamed file.jpg

Stock market outlook: Investors to track RBI policy and US tariffs; FII flows, rupee weakness to influence trend in holiday-shortened week

Indian equities are set for a data-heavy, holiday-shortened week in which the Reserve Bank of India’s policy decision, tariff-related developments and global cues will steer market sentiment, analysts said. Trading will remain shut on Thursday for Dussehra and Gandhi Jayanti.Alongside the RBI’s October 1 rate decision, investors will track key macro data such as industrial…

Read More
1 21.jpg

Asian drug market stocks slides: Trump’s 100% pharmaceutical tariffs shake market; broader impact on Japan likely minimal

Asian drug stocks fell on Friday as investors reacted to US President Donald Trump’s threat to impose 100% tariffs on imported branded pharmaceuticals starting October 1.Companies without existing US manufacturing plants could face the full impact, triggering declines across major drugmakers in South Korea, Japan, and Hong Kong.In South Korea, Samsung Biologics fell 1.6%, while…

Read More
1758810415 unnamed file.jpg

US market today: Wall Street slips for a third straight day as tech drags; bond yields rise on growth surprises

Wall Street struggled on Thursday, heading toward a rare three-day losing streak as investors digested stronger-than-expected US economic data and corporate results.The S&P 500 fell 0.7% in early trading, marking a deeper decline than the previous two days, while the Dow Jones Industrial Average was down 107 points, or 0.2%, and the Nasdaq composite slid…

Read More
1758805258 2.jpg

Anurag Kashyap BLAMES ‘star-driven’ audience and market for failure of Vikramaditya Motwane’s ‘Bhavesh Joshi Superhero’ |

Vikramaditya Motwane‘s ‘Bhavesh Joshi Superhero’, starring Harsh Varrdhan Kapoor, was an attempt by an Indian filmmaker to venture into vigilante dramas. However, it failed at the box office, and hence, the plans for a sequel were dropped. Eventually, the film received critical acclaim from the audience over the years. Filmmaker and producer of the movie,…

Read More
1 69.jpg

IPO rush in India’s pharma sector: Sector eyes Rs 12,000 crore fundraising; 15 companies ready to enter market

India’s pharmaceutical and healthcare industry is preparing for a significant wave of fundraising, with companies expected to raise Rs 12,000-13,000 crore through initial public offerings (IPOs) in the next six to nine months.According to ET, around 15 firms are likely to enter the primary market shortly. The Securities and Exchange Board of India (Sebi) has…

Read More